209 related articles for article (PubMed ID: 19688696)
1. CCM2 and CCM3 proteins contribute to vasculogenesis and angiogenesis in human placenta.
Tanriover G; Seval Y; Sati L; Gunel M; Demir N
Histol Histopathol; 2009 Oct; 24(10):1287-94. PubMed ID: 19688696
[TBL] [Abstract][Full Text] [Related]
2. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.
Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U
Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750
[TBL] [Abstract][Full Text] [Related]
3. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.
Stahl S; Gaetzner S; Voss K; Brackertz B; Schleider E; Sürücü O; Kunze E; Netzer C; Korenke C; Finckh U; Habek M; Poljakovic Z; Elbracht M; Rudnik-Schöneborn S; Bertalanffy H; Sure U; Felbor U
Hum Mutat; 2008 May; 29(5):709-17. PubMed ID: 18300272
[TBL] [Abstract][Full Text] [Related]
4. Genomic causes of multiple cerebral cavernous malformations in a Japanese population.
Tsutsumi S; Ogino I; Miyajima M; Ikeda T; Shindo N; Yasumoto Y; Ito M; Arai H
J Clin Neurosci; 2013 May; 20(5):667-9. PubMed ID: 23485406
[TBL] [Abstract][Full Text] [Related]
5. CCM2 expression during prenatal development and adult human neocortex.
Tanriover G; Sozen B; Gunel M; Demir N
Int J Dev Neurosci; 2011 Aug; 29(5):509-14. PubMed ID: 21569831
[TBL] [Abstract][Full Text] [Related]
6. CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations.
Voss K; Stahl S; Schleider E; Ullrich S; Nickel J; Mueller TD; Felbor U
Neurogenetics; 2007 Nov; 8(4):249-56. PubMed ID: 17657516
[TBL] [Abstract][Full Text] [Related]
7. CCM2-CCM3 interaction stabilizes their protein expression and permits endothelial network formation.
Draheim KM; Li X; Zhang R; Fisher OS; Villari G; Boggon TJ; Calderwood DA
J Cell Biol; 2015 Mar; 208(7):987-1001. PubMed ID: 25825518
[TBL] [Abstract][Full Text] [Related]
8. High-throughput sequencing of the entire genomic regions of CCM1/KRIT1, CCM2 and CCM3/PDCD10 to search for pathogenic deep-intronic splice mutations in cerebral cavernous malformations.
Rath M; Jenssen SE; Schwefel K; Spiegler S; Kleimeier D; Sperling C; Kaderali L; Felbor U
Eur J Med Genet; 2017 Sep; 60(9):479-484. PubMed ID: 28645800
[TBL] [Abstract][Full Text] [Related]
9. Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis.
Fischer A; Zalvide J; Faurobert E; Albiges-Rizo C; Tournier-Lasserve E
Trends Mol Med; 2013 May; 19(5):302-8. PubMed ID: 23506982
[TBL] [Abstract][Full Text] [Related]
10. A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells.
Pagenstecher A; Stahl S; Sure U; Felbor U
Hum Mol Genet; 2009 Mar; 18(5):911-8. PubMed ID: 19088124
[TBL] [Abstract][Full Text] [Related]
11. CCM3 and cerebral cavernous malformation disease.
Wang K; Zhou HJ; Wang M
Stroke Vasc Neurol; 2019 Jul; 4(2):67-70. PubMed ID: 31338212
[TBL] [Abstract][Full Text] [Related]
12. Mural Cell-Specific Deletion of Cerebral Cavernous Malformation 3 in the Brain Induces Cerebral Cavernous Malformations.
Wang K; Zhang H; He Y; Jiang Q; Tanaka Y; Park IH; Pober JS; Min W; Zhou HJ
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2171-2186. PubMed ID: 32640906
[TBL] [Abstract][Full Text] [Related]
13. Ccm3 functions in a manner distinct from Ccm1 and Ccm2 in a zebrafish model of CCM vascular disease.
Yoruk B; Gillers BS; Chi NC; Scott IC
Dev Biol; 2012 Feb; 362(2):121-31. PubMed ID: 22182521
[TBL] [Abstract][Full Text] [Related]
14. Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations.
You C; Sandalcioglu IE; Dammann P; Felbor U; Sure U; Zhu Y
J Cell Mol Med; 2013 Mar; 17(3):407-18. PubMed ID: 23388056
[TBL] [Abstract][Full Text] [Related]
15. A single-center study on 140 patients with cerebral cavernous malformations: 28 new pathogenic variants and functional characterization of a PDCD10 large deletion.
Nardella G; Visci G; Guarnieri V; Castellana S; Biagini T; Bisceglia L; Palumbo O; Trivisano M; Vaira C; Scerrati M; Debrasi D; D'Angelo V; Carella M; Merla G; Mazza T; Castori M; D'Agruma L; Fusco C
Hum Mutat; 2018 Dec; 39(12):1885-1900. PubMed ID: 30161288
[TBL] [Abstract][Full Text] [Related]
16. PDCD10, the gene mutated in cerebral cavernous malformation 3, is expressed in the neurovascular unit.
Tanriover G; Boylan AJ; Diluna ML; Pricola KL; Louvi A; Gunel M
Neurosurgery; 2008 Apr; 62(4):930-8; discussion 938. PubMed ID: 18496199
[TBL] [Abstract][Full Text] [Related]
17. CCM3/SERPINI1 bidirectional promoter variants in patients with cerebral cavernous malformations: a molecular and functional study.
Scimone C; Bramanti P; Ruggeri A; Donato L; Alafaci C; Crisafulli C; Mucciardi M; Rinaldi C; Sidoti A; D'Angelo R
BMC Med Genet; 2016 Oct; 17(1):74. PubMed ID: 27737651
[TBL] [Abstract][Full Text] [Related]
18. Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus.
Liquori CL; Berg MJ; Squitieri F; Ottenbacher M; Sorlie M; Leedom TP; Cannella M; Maglione V; Ptacek L; Johnson EW; Marchuk DA
Hum Mutat; 2006 Jan; 27(1):118. PubMed ID: 16329096
[TBL] [Abstract][Full Text] [Related]
19. Notch Signaling in Familial Cerebral Cavernous Malformations and Immunohistochemical Detection of Cleaved Notch1 Intracellular Domain.
Hasan SS; Fischer A
Methods Mol Biol; 2020; 2152():427-435. PubMed ID: 32524570
[TBL] [Abstract][Full Text] [Related]
20. Identification of a c.601C>G mutation in the CCM1 gene in a kindred with multiple skin, spinal and cerebral cavernous malformations.
Haghighi A; Fathi D; Shahbazi M; Motahari MM; Friedman B
J Neurol Sci; 2013 Nov; 334(1-2):97-101. PubMed ID: 24007869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
